Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 2442 | 43.99 |
09:34 ET | 1535 | 44.0711 |
09:36 ET | 1211 | 43.93 |
09:38 ET | 1338 | 43.78 |
09:41 ET | 200 | 43.18 |
09:45 ET | 100 | 42.84 |
09:48 ET | 100 | 43.0638 |
09:52 ET | 100 | 42.83 |
09:56 ET | 500 | 43.005 |
09:59 ET | 1453 | 42.72 |
10:01 ET | 434 | 42.625 |
10:03 ET | 700 | 42.87 |
10:06 ET | 1611 | 43 |
10:10 ET | 400 | 43.035 |
10:12 ET | 452 | 42.91 |
10:19 ET | 1368 | 43.01 |
10:24 ET | 300 | 42.89 |
10:30 ET | 774 | 42.97 |
10:32 ET | 9154 | 43.265 |
10:33 ET | 100 | 43.245 |
10:37 ET | 428 | 43.32 |
10:39 ET | 1500 | 43.37 |
10:42 ET | 300 | 43.61 |
10:44 ET | 1801 | 43.79 |
10:46 ET | 2900 | 43.7375 |
10:48 ET | 100 | 43.79 |
10:50 ET | 300 | 43.94 |
10:51 ET | 2268 | 43.835 |
10:53 ET | 897 | 44 |
11:00 ET | 100 | 43.9 |
11:04 ET | 2195 | 43.815 |
11:06 ET | 700 | 43.825 |
11:08 ET | 500 | 43.625 |
11:09 ET | 200 | 43.84 |
11:11 ET | 140 | 43.765 |
11:13 ET | 100 | 43.705 |
11:20 ET | 400 | 43.93 |
11:24 ET | 958 | 43.84 |
11:26 ET | 803 | 43.87 |
11:27 ET | 100 | 43.87 |
11:29 ET | 479 | 43.88 |
11:31 ET | 2033 | 44.105 |
11:36 ET | 2670 | 43.98 |
11:38 ET | 200 | 44.07 |
11:42 ET | 400 | 43.97 |
11:44 ET | 500 | 43.99 |
11:51 ET | 400 | 43.87 |
11:54 ET | 100 | 43.89 |
11:56 ET | 200 | 43.91 |
12:02 ET | 9082 | 43.35 |
12:03 ET | 600 | 43.465 |
12:05 ET | 636 | 43.3 |
12:09 ET | 200 | 43.26 |
12:14 ET | 200 | 43.34 |
12:16 ET | 603 | 43.13 |
12:18 ET | 200 | 43.105 |
12:20 ET | 100 | 43.04 |
12:21 ET | 100 | 43.14 |
12:23 ET | 100 | 42.965 |
12:25 ET | 976 | 43.13 |
12:30 ET | 512 | 43.185 |
12:32 ET | 23402 | 43 |
12:34 ET | 16553 | 42.95 |
12:36 ET | 51121 | 42.845 |
12:38 ET | 100 | 42.81 |
12:39 ET | 100 | 42.92 |
12:41 ET | 4739 | 43 |
12:43 ET | 4890 | 43 |
12:45 ET | 100 | 42.785 |
12:50 ET | 200 | 42.735 |
12:54 ET | 300 | 42.58 |
12:59 ET | 100 | 42.595 |
01:06 ET | 672 | 42.601 |
01:08 ET | 3704 | 42.5 |
01:10 ET | 760 | 42.525 |
01:14 ET | 719 | 42.39 |
01:17 ET | 1348 | 42.345 |
01:19 ET | 8624 | 42.11 |
01:21 ET | 600 | 42.11 |
01:28 ET | 100 | 42.03 |
01:30 ET | 314 | 42.1 |
01:33 ET | 7934 | 41.905 |
01:35 ET | 100 | 42 |
01:37 ET | 1600 | 42.04 |
01:42 ET | 800 | 42.14 |
01:44 ET | 100 | 42.135 |
01:46 ET | 217 | 42.13 |
01:48 ET | 300 | 42.1699 |
01:51 ET | 100 | 42.125 |
01:53 ET | 400 | 42.1125 |
01:57 ET | 400 | 42.095 |
02:02 ET | 500 | 42.16 |
02:06 ET | 400 | 42.2 |
02:08 ET | 100 | 42.19 |
02:18 ET | 500 | 42.26 |
02:20 ET | 100 | 42.32 |
02:22 ET | 100 | 42.305 |
02:26 ET | 1200 | 42.43 |
02:29 ET | 300 | 42.4225 |
02:33 ET | 11958 | 42.815 |
02:36 ET | 200 | 42.795 |
02:38 ET | 400 | 42.8 |
02:42 ET | 17570 | 42.96 |
02:44 ET | 1700 | 42.99 |
02:45 ET | 1500 | 42.91 |
02:47 ET | 2100 | 42.88 |
02:49 ET | 200 | 42.915 |
02:54 ET | 2681 | 42.83 |
03:00 ET | 200 | 42.96 |
03:02 ET | 400 | 43.04 |
03:05 ET | 810 | 43.1 |
03:07 ET | 200 | 43.1 |
03:12 ET | 1100 | 43.15 |
03:14 ET | 160 | 43.155 |
03:16 ET | 900 | 43.14 |
03:18 ET | 1564 | 43.025 |
03:20 ET | 29500 | 42.965 |
03:21 ET | 200 | 42.94 |
03:25 ET | 308 | 42.95 |
03:27 ET | 200 | 42.96 |
03:30 ET | 600 | 43.025 |
03:32 ET | 1100 | 42.8 |
03:34 ET | 600 | 42.68 |
03:36 ET | 800 | 42.755 |
03:41 ET | 1300 | 42.71 |
03:45 ET | 217 | 42.735 |
03:48 ET | 1250 | 42.84 |
03:50 ET | 1050 | 42.78 |
03:52 ET | 1400 | 42.89 |
03:54 ET | 3565 | 43 |
03:56 ET | 4750 | 42.9 |
03:57 ET | 15067 | 42.9 |
03:59 ET | 2350 | 42.86 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 2.0B | -17.1x | --- |
Syndax Pharmaceuticals Inc | 2.0B | -8.0x | --- |
Geron Corp | 1.9B | -10.2x | --- |
Janux Therapeutics Inc | 1.9B | -28.1x | --- |
Neumora Therapeutics Inc | 2.2B | -5.9x | --- |
Sana Biotechnology Inc | 2.2B | -6.8x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.0B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 46.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.51 |
Book Value | $9.76 |
P/E Ratio | -17.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.